Serumkonzentrationen der löslichen Adhäsionsmoleküle sICAM-1 und sVCAM-1 bei Patienten mit malignen HNO-Tumoren

Kaptur, S.; Riedel, Frank; Erhardt, T.; Hörmann, K.

doi:10.1007/s001060170017

Search citation statements

Order By: Relevance

Paper Sections

Select...

Marker Bei Plattenepithelkarzinomen Der Mundhöhle1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2003

2013

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Expression und Langzeitverlauf von VEGF, FLT-1 und Tie2 im Serum moleküle im Plasma bzw.Serum bei KopfHals-Tumoren sind bereits untersucht worden [1,5,9,16].…”

Section: Marker Bei Plattenepithelkarzinomen Der Mundhöhleunclassified

Marker bei Plattenepithelkarzinomen der Mundh�hle

Schimming

Gellrich

Eyrich

2004

HNO

View full text Add to dashboard Cite

show abstract

“…Expression und Langzeitverlauf von VEGF, FLT-1 und Tie2 im Serum moleküle im Plasma bzw.Serum bei KopfHals-Tumoren sind bereits untersucht worden [1,5,9,16].…”

Section: Marker Bei Plattenepithelkarzinomen Der Mundhöhleunclassified

Marker bei Plattenepithelkarzinomen der Mundh�hle

Schimming

Gellrich

Eyrich

2004

HNO

View full text Add to dashboard Cite

show abstract

Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma

Ding

Chen²,

Xia³

et al. 2003

WJG

132

View full text Add to dashboard Cite

The expression of VCAM-1 is closely related to oncogenesis, tumor angiogenesis and metastasis in gastric carcinoma. Serum VCAM-1 level in gastric cancer patients is significantly increased compared with normal controls, which decreases significantly after radical resection of the primary tumor. The serum concentration of VCAM-1 may be considered as an effective marker of tumor burden of gastric cancer. Moreover, overexpression of VCAM-1 in gastric cancer tissue is likely a major source of serum VCAM-1.

show abstract

Current molecular biology research contributing to the early diagnosis of oral cancer (Review Article)

Katsuhiro¹,

Kasamatsu²,

Baba³

et al. 2013

J Jpn Soc Oral Tumor

View full text Add to dashboard Cite

On the basis of research results of the past few decades, it is widely accepted that tumor-derived cells (CTCs) or circulating tumor-derived nucleic acids (ctNAs) found in the circulation of cancer patients might be a sign of micrometastases and thus could be an important predictor of prognosis. It is possible to estimate CTCs/ctNAs by immunocytochemical or molecular assays and these assays might also be used to monitor signs not only systemically but also in real-time in patients with malignant tumors. In this article, we discuss the transition of CTCs/ctNAs from the research setting to clinical application in oral cancer, especially our current research findings. Key words：circulating tumor-derived cells, circulating tumor-derived nucleic acids, mitochondrial DNAs, micro metas tasis, oral cancer prognosis

show abstract

Serumkonzentrationen der löslichen Adhäsionsmoleküle sICAM-1 und sVCAM-1 bei Patienten mit malignen HNO-Tumoren

Cited by 3 publications

References 17 publications

Marker bei Plattenepithelkarzinomen der Mundh�hle

Marker bei Plattenepithelkarzinomen der Mundh�hle

Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma

Current molecular biology research contributing to the early diagnosis of oral cancer (Review Article)

Contact Info

Product

Resources

About